bell
The current prices are delayed by 15 mins, login to check live prices.
Aarti Drugs Ltd share price logo

Aarti Drugs Ltd

(AARTIDRUGS)

₹445.150.26%

as on 04:01PM, 13 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Aarti Drugs Ltd Analyst Rating

based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts offering long term price targets for Aarti Drugs Ltd. An average target of ₹555

Source: S&P Global Market Intelligence

Aarti Drugs Ltd Share analysis

Aarti Drugs Ltd price forecast by 1 analysts

Upside of24.36%

High

₹555

Target

₹555.00

Low

₹555

Aarti Drugs Ltd target price ₹555, a slight upside of 24.36% compared to current price of ₹445.15. According to 1 analysts rating.

Source: S&P Global Market Intelligence

Aarti Drugs Ltd Performance

  • Day's Low

    Day's High

    ₹437.95
    ₹447.8
  • 52 Week's Low

    52 Week's High

    ₹431.05
    ₹635
1 Month Return-4.51 %
3 Month Return-14.98 %
1 Year Return-7.35 %
Previous Close₹446.30
Open₹446.30
Volume1.36L
Upper Circuit-
Lower Circuit-
Market Cap₹4,103.06Cr

Aarti Drugs Ltd Key Statistics

P/E Ratio26.9
PEG Ratio-9.24
Market Cap₹4,103.06 Cr
P/B Ratio3.39
EPS18.66
Dividend Yield0.23
SectorPharmaceuticals
ROE12.39

Aarti Drugs Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹4,103.06 Cr50.86%0.64₹171 Cr₹2,528 Cr
HOLD₹32,491.40 Cr131.47%0.52₹300 Cr₹1,051 Cr
BUY₹17,918.06 Cr29.23%0.57₹72 Cr₹6,702 Cr
NA₹6,984.68 Cr5.78%0.79-₹388 Cr₹75 Cr
BUY₹16,534.14 Cr52.33%0.68₹218 Cr₹1,296 Cr

About Aarti Drugs Ltd

Aarti Drugs Limited is a leading manufacturer of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals. Part of the USD 1500 million Aarti Group, it has two RD divisions in Tarapur and Turbhe, Maharashtra; and three wholly-owned subsidiaries, namely Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA, a foreign subsidiary. It has expanded its production capacity from 598,000kg in 1993 to 25,716,000kg in 2021. In 2020 it incorporated two overseas subsidiaries and one domestic one, while the one in 2021 was wound up as it didn’t have any business activity. Aarti Drugs also carries out research and development on key products such as antihistaminic/antiallergic, antiinflammatory and antidiabetic. Its GMP-certified plant can manufacture Benzene Sulphonyl Chloride, Benzene Sulphonic Acid/ Ammonium/ Sodium Salt and Benzene Sulphonamide. With 50 compounds formed for Antibiotics, Anti Protozoal, AntiInflammatory, Antidiabetic, Anti Fungal and Cardioprotectant therapeutic segments, it is a market leader in API segment.

Share Price: ₹445.15 per share as on 13 Dec, 2024 04:01 PM
Market Capitalisation: ₹4,103.06Cr as of today
Revenue: ₹598.33Cr as on September 2024 (Q3 24)
Net Profit: ₹34.96Cr as on September 2024 (Q3 24)
Listing date: 03 Oct, 1996
Chairperson Name: Prakash M Patil
OrganisationAarti Drugs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Aarti Drugs Ltd

  • Aarti Drugs Faces Decline After Weak Q2 Results - 25 Oct, 2024

    Aarti Drugs reported significant declines in revenue and profit for Q2 FY25, leading to a drop in share prices. Consolidated net profit fell 11.57%, and standalone sales decreased 5.96% YoY. Investor concerns grew as the company faced challenging financial results.
  • Aarti Drugs Gains GMP Certification, Shares Rise - 04 Oct, 2024

    Aarti Drugs' subsidiary, Pinnacle Life Science, received a GMP compliance certificate from UK MHRA, enabling UK exports. Shares rose 3% following the announcement.

Insights on Aarti Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 5.70% to 6.25% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 556.45 Cr → 599.81 Cr (in ₹), with an average increase of 7.2% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 33.24 Cr → 35.01 Cr (in ₹), with an average increase of 5.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 62.8% return, outperforming this stock by 70.1%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 34.02% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 136.8% return, outperforming this stock by 159.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.96% to 2.50% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 55.67% to 55.64% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, AARTIDRUGS stock has moved down by -4.5%

Aarti Drugs Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹641.54Cr (-)₹605.94Cr (↓5.55%)₹619.99Cr (↑2.32%)₹555.34Cr (↓10.43%)₹598.33Cr (↑7.74%)
Net Income₹39.60Cr (-)₹36.71Cr (↓7.30%)₹47.31Cr (↑28.87%)₹33.27Cr (↓29.68%)₹34.96Cr (↑5.08%)
Net Profit Margin6.17% (-)6.06% (↓1.78%)7.63% (↑25.91%)5.99% (↓21.49%)5.84% (↓2.50%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,637.00Cr (-)₹2,034.51Cr (↑24.28%)₹2,195.49Cr (↑7.91%)₹2,171.63Cr (↓1.09%)
Total Liabilities₹777.39Cr (-)₹1,062.34Cr (↑36.65%)₹1,081.19Cr (↑1.77%)₹996.42Cr (↓7.84%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹196.15Cr (-)₹154.18Cr (↓21.40%)₹39.90Cr (↓74.12%)₹161.70Cr (↑305.26%)₹337.10Cr (↑108.47%)

Index Inclusions

BSE Healthcare

₹44,049.87

-0.29 (-127%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹56,957.46

-0.29 (-167.68%)

Aarti Drugs Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
55.64%
-0.05
Foreign Institutions
2.5%
-15.31
Mutual Funds
6.25%
9.64
Retail Investors
34.02%
0.00
Others
1.58%
-4.06

Aarti Drugs Ltd Key Indicators

Details20202021202220232024
Return On Assets %9.6117.1310.087.587.89
Details20202021202220232024
Book Value Per Share (₹)70.0198.01111.92128.77139.4
Details20202021202220232024
Earning Per Share (₹)15.1730.0922.1417.9718.66
Details20202021202220232024
Return On Equity %23.7934.7921.2914.6512.39

Aarti Drugs Ltd Valuation

Aarti Drugs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (8.29x)

March 31, 2020

Today (26.90x)

December 12, 2024

Industry (56.92x)

December 12, 2024

Highest (57.24x)

August 24, 2020

LowHigh

Aarti Drugs Ltd Earnings and Dividends

  • Aarti Drugs Ltd Earnings Results

    Aarti Drugs Ltd’s net profit fell -11.57% since last year same period to ₹35.01Cr in the Q2 2024-2025. On a quarterly growth basis, Aarti Drugs Ltd has generated 5.32% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Aarti Drugs Ltd Dividends January,2024

    In the quarter ending December 2023, Aarti Drugs Ltd has declared dividend of ₹1 - translating a dividend yield of 0.45%.

    Read More about Dividends

Aarti Drugs Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Aarti Drugs Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Aarti Drugs Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Aarti Drugs Ltd shares.

Aarti Drugs Ltd (AARTIDRUGS) share price today is ₹445.15

Aarti Drugs Ltd is listed on NSE

Aarti Drugs Ltd is listed on BSE

  • Today’s highest price of Aarti Drugs Ltd is ₹447.8.
  • Today’s lowest price of Aarti Drugs Ltd is ₹437.95.

PE Ratio of Aarti Drugs Ltd is 26.9

PE ratio = Aarti Drugs Ltd Market price per share / Aarti Drugs Ltd Earnings per share

Today’s traded volume of Aarti Drugs Ltd(AARTIDRUGS) is 1.36L.

Today’s market capitalisation of Aarti Drugs Ltd(AARTIDRUGS) is ₹4103.06Cr.

Aarti Drugs Ltd(AARTIDRUGSPrice
52 Week High
₹635
52 Week Low
₹431.05

Aarti Drugs Ltd(AARTIDRUGS) share price is ₹445.15. It is down -29.90% from its 52 Week High price of ₹635

Aarti Drugs Ltd(AARTIDRUGS) share price is ₹445.15. It is up 3.27% from its 52 Week Low price of ₹431.05

Aarti Drugs Ltd(AARTIDRUGSReturns
1 Day Returns
-1.15%
1 Month Returns
-4.51%
3 Month Returns
-14.98%
1 Year Returns
-7.35%